Pay in 4 interest-free payments of $7.47 Learn more
Ships within 48 hours · Estimated delivery Nov 2 - Nov 7
BPC-157 fits into that structure as a steady background note, supporting micro-healing while practice, labor, or training creates the primary stimulus
January 1, 2022
Tirzepatide GLP-1 is a dual-action metabolic therapy that supports weight control by improving insulin sensitivity, reducing appetite, and enhancing satiety
PubMed laboratory research record [PMID: 15774286] PubMed record related to this compound for laboratory literature review
Sitting or lying down until the dizziness passes can help, but persistent dizziness should be evaluated by a healthcare provider
Molecular Identity Full Name Body Protection Compound 157 Structure Pentadecapeptide (15 amino acids) Sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val Molecular Weight ~1419 g/mol Origin Synthetic fragment derived from human gastric juice protein Mechanism of Action Published research identifies several pathways through which BPC-157 may affect tissue: Angiogenesis promotion: Studies show BPC-157 promotes blood vessel formation in animal models (Seiwerth et al., 2018) Nitric oxide system modulation: Interactions with NO pathways have been documented Growth factor activity: Research indicates effects on VEGF and EGF pathways FAK-paxillin pathway: Cell migration studies show activation of focal adhesion kinase Published Research Study Focus Model Publication Seiwerth et al
